Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» US WorldMeds
US WorldMeds
US WorldMeds' Iwilfin bags FDA nod as 1st oral maintenance treatment for high-risk neuroblastoma
Fierce Pharma
Thu, 12/14/23 - 10:52 pm
US WorldMeds
Iwilfin
FDA
neuroblastoma
FDA adcomm backs US WorldMeds’ potential high-risk pediatric neuroblastoma drug
Medical Marketing and Media
Thu, 10/5/23 - 11:33 am
US WorldMeds
FDA
pediatric neuroblastoma
clinical trials
eflornithine
Supernus Makes a Parkinson’s Play With $300M Deal for US WorldMeds Drugs
Xconomy
Wed, 04/29/20 - 10:43 pm
Supernus Pharmaceuticals
US WorldMeds
Salix, US WorldMeds eye 2019 push into the mainstream for opioid withdrawal drug Lucemyra
Fierce Pharma
Mon, 08/13/18 - 10:56 am
Salix
US WorldMeds
physicians
opioids
opioid withdrawal
Lucemyra
Valeant signs with WorldMeds to hawk first-ever opioid withdrawal drug Lucemyra
Fierce Pharma
Thu, 06/28/18 - 07:06 pm
US WorldMeds
FDA
Lucemyra
opioid withdrawal
Valeant Pharmaceuticals
Salix
In a first, FDA approves drug meant to mitigate symptoms of opioid withdrawal
Stat
Wed, 05/16/18 - 10:51 pm
FDA
Lucemyra
US WorldMeds
opioid withdrawal
opioids